| Previous Close | 19.80 |
| Open | 19.80 |
| Bid | 10.15 x 100 |
| Ask | 20.25 x 100 |
| Day's Range | 19.60 - 20.20 |
| 52 Week Range | 11.56 - 20.20 |
| Volume | 213,861 |
| Avg. Volume | 162,081 |
| Market Cap | 653.57M |
| Beta | 0.48 |
| PE Ratio (TTM) | 63.80 |
| EPS (TTM) | 0.31 |
| Earnings Date | Jul 24, 2017 - Jul 28, 2017 |
| Dividend & Yield | 0.00 (0.00%) |
| Ex-Dividend Date | 2015-12-09 |
| 1y Target Est | 23.00 |
- Zacks•8 hours ago
Quintiles' (Q) OCE Software to Simplify Commercial Functions
QuintilesIMS (Q) announced the general availability of Orchestrated Customer Engagement (OCE) software to streamline pharmaceutical commercial functions.
- Capital Cube•yesterday
ETFs with exposure to CryoLife, Inc. : June 26, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to CryoLife, Inc. Here are 5 ETFs with the largest exposure to CRY-US. Comparing the performance and risk of CryoLife, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Zacks•5 days ago
Luminex (LMNX) Banks on Portfolio Strength, View Impressive
On Jun 21, we issued an updated research report on Austin, TX-based Luminex Corp (LMNX) -- a manufacturer and marketer of proprietary biological testing technologies with applications throughout the life sciences and diagnostics industry.
